always looking for a good trade
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree..very strong!
Again my note, because it is importante:
"when investors realize that 0,0002-0,0004 are still good entry prices this will get even more interesting to the move towards the 0,001 area."
And i believe in this new CEO and VersaGreen have a good core business.
So, i will hold my 30Million long and not dump.
This are times to buy TGGI, i think the majority understand that one single good news and this will go much higher.
My opinion,once more
thanks
Ya, and when investors realize that 0,0002-0,0004 are still good entry prices this will get even more interesting to the move towards the 0,001 area.
it always dificult to guess what will be the top, however it seems this company has a good core business that could send the share price up.
I think 0,0001 is nothing... Step by step...first move into 0,0004 area and than 0,001.
I personally like the new management...my target is to achieve the 50Million shares.
As shareholder for short term it is clear that won´t be a R/S what is good...
And i also think that Dec-12 and Jan-12 will be very interesting months for this company and for all sharehollders.
Best Regards
Agree.Nice
I am still in with 30M. This are in a melting point, a litle more push on the buy side and this will rock like BCAP.
My opinion and i am holding for quite some time.
Best Regards
Just a important note about PATH:
I think there was a bad interpretation about this news:
http://www.theflyonthewall.com/permalinks/entry.php/PATHid1732760/PATH-NuPathe-files-to-sell-M-shares-of-common-stock-for-holders
"The filing you referenced has to do with registering the 10/23/2012 offering and some previous shares. These are not new
This is an answer to a question that i have made to PATH.
I think this will help to understand they don´t have plan to sell more shares at least a short term. The have ennough money as we saw in the Q3.
Best Regards
Don´t worry there are people that are holding in the sidelines with 30M shares.
I am one of them.
We could see this going into 0,001-0,0015 area.
Since the change of the CEO i believe in this company.
Best Regards for all.
There are no sec filling about the sale of 40.78M shares:
http://google.brand.edgar-online.com/?sym=PATH
Excellent board, excellent members and excellent information.
Keep the good work.
Just enjoying the happy hour to say that.
Best Regards
-maybe i will add to.
WITH $24 P.T. I DON´T KNOW WHERE WILL STOP.
AHEAD WE WILL HAVE PARTNERSHIP AND PH II/III RESULTS AND IF THEY WERE GOOD AS EXPECTED I REALLY DON´T KNOW...
REGARDS
About FDA decisions i like to see here:
http://www.biopharmcatalyst.com/fda-calendar/
About SGYP, well at seeking alpha you have many articles about.
My opinion is very bullish about. The should increase in the next months. Could spkike at 9 of september or when PHII/III results were present.
I understand your words, but i am only doing research about their drugs and how that will affect the share price.
Hope you get a better agremente on sgyp shares, because a i really believe they have a lot to go up.
Best regards for you
Additionally, Aegis Capital Cor tagged SGYP last Tuesday with a price target of $25 following the announcement of the trial completion. Aegis also noted the expectations of positive trial results and the potential of Plecanatide on the open market. In terms of valuation, Aegis noted the following:
"Synergy's current market cap of about $250mm does not adequately value the potential of Plecanatide and the firm's platform technology, in our view. We also note that linaclotide is currently valued at a level approaching $3bn based on the market cap of Ironwood Pharmaceuticals (IRWD/NASDAQ - Buy), the originator of this agent."
The Aegis valuation also likely played a factor in SGYP's rebound. The next few months will make or break Synergy and the catalysts are due to start rolling in at a rapid pace in just weeks. Since the markets trade ahead of news, look for continued movement and volatility in the SGYP share price. A hot story in the sector to watch for the coming week, and for well into the third and fourth quarters
in, http://seekingalpha.com/article/817411-weekly-stock-watch-for-august-20
PT above $8 and only 6 followers in this board...lol....Anyone have time to the moderator?
I don´t know much about the merger agreement, but at the end i think they will in also with the increase in the sgyp share price.
I traded DCTH last month also.
I own SGYP, CYTK, and CBRX.
And i am waiting for dilution in PATH in Q3 to buy before the new FDA date.
Well, thoughts on CBRX could be pure speculation. But 2 key points
1) Cowen and Company seeking are seeking what will be best for CBRX shareholders. Could be a merger, a buyout scenario or something else...Or Watson could by more shares and own more than 50% of CBRX...It is hard to say what will happen...
2) Watson find a pathway and FDA approval the PPS could go to $3-$5
3)Yes they have a good balance sheet and thats what this company have on their favor. And i think we could see a PPS around $1,5.However if the point 2 were true the EPS ratio of 21.2 won´t be enough...lol
Speculation will drive the PPS much higher in Q3 in Q4. Lets see how institucional investors will do.
Very quiet here, while the share price increase more than 20%...
I am following this for quiet some time and seems a good investment.
This will be probably the August and Setember Play....
This should be a win-win play on setember 9. If FDA doesn´t approve IRWD drug SGYP will climb hard. But if IRWD drug were approved SGYP will win also, because (in my opinion) SGYP drug will show the some efficiency and less side effects.
I still own. I think this is a long play and a good one.
Sorry i have been out and i don´t have much time to be in ihub.
My holding now are CYTK, SGYP and CBRX.
Best Regards
Im in in SGYP, CBRX and CYTK now.
SGYP bougt at 3,96: I am expecting a strong move in SGYP.9 of Setember will be an important day.
CBRX bought at 0,76: Expecting buyout or a deal
CYTR: Average at 0,72: Long play.
Sorry. I have been out and my time to follow the isn´t to much for now.
Exactly!
First 0,75 and after $1. Lets see....
I am expecting a move for first to the $0,75 area first and if holds going to $1 area
"Lastly, in recent months, we also have been reforming our plans for studies and potential indications that we may pursue beyond ALS and with potential partners. These are exciting and important times for us in the development of tirasemtiv."
Like this words
Expecting a good day. Ya still need to break those 0,75.
Strange sell orders...100 or 200..?Anyone see that?
I won´t waste more time. Will buy 12.5K shares today.
They are excellent, so much trials ongoing and 90Millions in cash. Once this start move really, nothing will stop CYTK.
Agree also. This has so much to move up.
ALmost 4% in after hours.
It is amazing all the pipeline and ongoing trials.
Should move nice today and tomorrow.
Hi Trader
I follow only small cap pharmaceutical companies.
I looking for a breakout in CYTK (for a trade between 0,75-1).
And a couple more that will share with you and board.
Regards
Good Afternoon. New to this board.
I also have some picks that i will post soon here.
Regards
Sorry wrong company...CYTK.
The Pipeline Value could make CYTR more than 1Billion mar. cap. company, of course after approaval of their drugs.
Really amazing.